GI Updates from ECCO 14 Conference (Sept 23-27, Barcelona, Spain)

posted Oct 22 2007
We would like to thank Dr Scott Berry, Dr Chris Booth & Dr Phil Bedard for providing us with the latest conference updates

ECCO 14 Conference Updates

5-year overall survival update from the X-ACT trial of capecitabine vs 5-FU/LV as adjuvant treatment for stage III colon cancer

Final Results From a Phase II, Randomized, Double-blind Study of Sorafenib Plus Doxorubicin Versus Placebo Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma